Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Down 41.2% in February

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a large decline in short interest in February. As of February 28th, there was short interest totalling 2,000 shares, a decline of 41.2% from the February 13th total of 3,400 shares. Based on an average daily volume of 9,100 shares, the short-interest ratio is presently 0.2 days.

Lexaria Bioscience Trading Up 29.2 %

Shares of Lexaria Bioscience stock opened at $0.26 on Friday. Lexaria Bioscience has a 1 year low of $0.16 and a 1 year high of $2.07. The firm’s 50-day moving average is $0.39 and its 200 day moving average is $0.70.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.